🚨 #BREAKING Eli Lilly publishes trial results for new weight-loss drug

Pharmaceutical giant Eli Lilly published late-stage clinical trial data today showing that its new experimental drug, retatrutide, helped people lose an average of 25 percent of their body weight after 80 weeks. 📉

The trial started back in 2023 to test a unique triple-hormone formula, pushing weight loss further than existing treatments like Zepbound and Wegovy.

Besides dropping pounds, the weekly injection also eased knee pain and reversed prediabetes in over 90 percent of affected participants. 💪

#health #science #weightloss

Subscribe